Author

Neil Desai

Observed name: Neil B. Desai

Institutions: Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

Observed institutions: Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

OpenAlex ID: A5133350231

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026

2026 · Daniel E. Spratt, Sandy Srinivas, et al. · Journal of the National Comprehensive Cancer Network · 11

Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients

2026 · Luca F. Valle, Tahmineh Romero-Kalbasi, et al. · European Urology Oncology · 2

Stereotactic Ablative Radiation Therapy for Oligoprogressive Metastatic RCC: Predictors of Prolonged Benefit from Ongoing Systemic Therapy

2026 · Lucian Zhao, Dana Keilty, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Using artificial intelligence for radiotherapy clinical trial quality assurance: analysis of a multi-institutional clinical trial for neurovascular-sparing prostate stereotactic ablative radiotherapy

2026 · Matt Doucette, Ying Zhang, et al. · medRxiv

Clinical outcomes for patients (pts) with synchronous versus metachronous metastatic urothelial cancer (mUC) treated with enfortumab vedotin and pembrolizumab (EV-P).

2026 · Libin Yan, Lin Lin, et al. · Journal of Clinical Oncology

Metastasis-directed Therapy in Oligometastatic Castration-resistant Prostate Cancer: From Chasing the Last Metastasis to Changing the Game?

2026 · Thomas Zilli, Nicholas G. Zaorsky, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 6

Citation count: 15

H-index: 2

I10-index: 1